Clonazepam-Associated Bradycardia
Clonazepam (a benzodiazepine) exposure has been associated with bradycardia and transient conduction abnormalities in published case reports. [1,2]
Evidence for Bradycardia With Clonazepam Exposure
Transient sinus bradycardia and atrioventricular (AV) block have been reported after benzodiazepine exposure that included clonazepam ingestion. [1] A pediatric case with clonazepam ingestion showed first-degree AV block on presentation and progression to second-degree AV block after flumazenil, with resolution on subsequent monitoring. [1] A separate adult case with benzodiazepine exposure showed sinus bradycardia on arrival and subsequent second-degree AV block, with resolution on repeat testing. [1] An additional case report described extreme bradycardia in the setting of clonazepam intoxication during body-stuffing. [2]
Dose-Response Considerations for 0.5 mg
The cited reports describe bradycardia/conduction abnormalities in the setting of clonazepam exposure sufficient to cause marked clinical toxicity or intoxication rather than clearly documented effects from a single 0.5 mg therapeutic dose. [1,2]
Clinical Implications
Bradycardia after clonazepam warrants assessment for intoxication severity and for contributing factors such as other sedatives, underlying conduction disease, and physiologic triggers (hypoxia, electrolyte abnormalities). [1,2] Urgent emergency evaluation is indicated for symptomatic bradycardia (syncope, hypotension, chest pain, dyspnea) or persistent marked bradycardia after medication exposure. [1,2]